ACCC is seeking feedback from the public on whether the draft undertaking will address the competition concerns arising from its proposed merger.
The ACCC is seeking views on a proposed court-enforceable undertaking offered by Sigma Healthcare Limited (ASX: SIG) in relation to its proposed acquisition of Chemist Warehouse Group Holdings.
ACCC Chair Gina Cass-Gottlieb said, “we are now seeking feedback from stakeholders on whether the draft undertaking offered by Sigma may be capable of addressing the competition concerns arising from its proposed acquisition of Chemist Warehouse”.
The ACCC is continuing to investigate the impact of the proposed acquisition.
“While the ACCC is publicly consulting on this undertaking, this should not be interpreted to mean that this or any other form of undertaking will ultimately be accepted by the ACCC,” Cass-Gottlieb said.
More details in today’s issue of Pharmacy Daily.
